Literature DB >> 15487318

Genotypic differences of Candida albicans and C. dubliniensis isolates related to ethnic/racial differences within the same geographic area.

Michael J McCullough1, Jacks J Jorge, Flavio Lejbkowicz, Eli Lefler, Faris Nassar, Karl V Clemons, David A Stevens.   

Abstract

Candida albicans and C. dubliniensis genotype differences among Israeli ethnic groups were assessed. Isolates from Jews (51), Arabs (35) and Druze (25) were genotyped. The distributions among ethnic groups were not different, however they differed (p = 0.002) from global populations. Therefore, C. albicans and C. dubliniensis genotype distribution differences in Israel are related to changes in all ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15487318     DOI: 10.1023/b:myco.0000038432.94844.f7

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  9 in total

1.  Molecular epidemiology of the global and temporal diversity of Candida albicans.

Authors:  M J McCullough; K V Clemons; D A Stevens
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

2.  Ca3 fingerprinting of Candida albicans isolates from human immunodeficiency virus-positive and healthy individuals reveals a new clade in South Africa.

Authors:  Elaine Blignaut; Claude Pujol; Shawn Lockhart; Sophie Joly; David R Soll
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Molecular epidemiology of Candida albicans isolates from AIDS and cancer patients using a novel standardized CARE-2 DNA fingerprinting technique.

Authors:  A Lischewski; D Harmsen; K Wilms; G Baier; U Gunzer; H Klinker; M Wilhelm; A Schwinn; J Hacker
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

4.  Comparative analysis of genetic variability among Candida albicans isolates from different geographic locales by three genotypic methods.

Authors:  K V Clemons; F Feroze; K Holmberg; D A Stevens
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

Review 5.  Candida dubliniensis: an emerging opportunistic pathogen.

Authors:  D Sullivan; D Coleman
Journal:  Curr Top Med Mycol       Date:  1997-12

6.  DNA- and PCR-fingerprinting in fungi.

Authors:  W Meyer; E Lieckfeldt; K Kuhls; E Z Freedman; T Börner; T G Mitchell
Journal:  EXS       Date:  1993

7.  Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea.

Authors:  M J McCullough; K V Clemons; D A Stevens
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

8.  Epidemiological analysis of Candida yeasts by pulsed-field gel electrophoresis.

Authors:  B Willinger; A Berger; L Li; A M Hirschl; C Aspöck; A Makristathis; M Prückl; M L Rotter
Journal:  Mycoses       Date:  1994 Nov-Dec       Impact factor: 4.377

9.  Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype.

Authors:  D A Stevens; F C Odds; S Scherer
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr
  9 in total
  5 in total

1.  Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting.

Authors:  Asmaa Al Mosaid; Derek J Sullivan; Itzhack Polacheck; Faisal A Shaheen; Osama Soliman; Saleh Al Hedaithy; Sahar Al Thawad; Motaz Kabadaya; David C Coleman
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

2.  Clonal population structure and genetic diversity of Candida albicans in AIDS patients from Abidjan (Côte d'Ivoire).

Authors:  François Nébavi; Francisco J Ayala; François Renaud; Sébastien Bertout; Serge Eholié; Koné Moussa; Michèle Mallié; Thierry de Meeûs
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-24       Impact factor: 11.205

Review 3.  Candida dubliniensis: epidemiology and phenotypic methods for identification.

Authors:  Erico Silva Loreto; Liliane A Scheid; Cristina W Nogueira; Gilson Zeni; Janio M Santurio; Sydney H Alves
Journal:  Mycopathologia       Date:  2010-02-21       Impact factor: 2.574

4.  Current awareness on yeast.

Authors: 
Journal:  Yeast       Date:  2005-01-30       Impact factor: 3.239

5.  Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial.

Authors:  Piroon Mootsikapun; Po-Ren Hsueh; Deepak Talwar; Vilma M Co; Viraj Rajadhyaksha; Moh-Lim Ong
Journal:  BMC Infect Dis       Date:  2013-05-15       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.